The prevalence of school absenteeism in asthmatic children has had little systematic attention from paediatricians, who are mainly concerned with the causation and treatment of this disease. This aspect clearly seems to be deserving of attention from a clinical viewpoint, and this paper summarizes some initial results which reveal that asthma is indeed a frequent cause of recurrent absence from school, and that this situation can be much improved.
There is a surprising lack of available data on school absenteeism in asthmatic children, but some idea of the scope of the problem may be obtained from known facts about the incidence of asthma in children of school age. Eilertsen (1954) reported an incidence of 1-8 % amongst 7-year-old schoolchildren in Bergen, while Kraepelien (1954) drew attention to a figure of 1 4% in the 7 to 14 agegroup in Stockholm. Smith (1961) (see below) . Conversely, in one case, 10-hourly doses were given by the mother before relieving the child of wheeze, and there was no adverse reaction. This suggests that the margin of safety is considerable. This experience was most encouraging, as it showed that it was possible to prescribe a large amount of orciprenaline to relieve the condition and so ensure that failure was not the result of inadequate dosage.
Treatment in the first attack. Of the total of 46 children, 6 were in their first attack, and in these HEDT was used initially and the patients were then stabilized 'wheeze-free' using morning and evening dosage alone. The response of these 'neo-asthmatics' was such that it was unnecessary to teach them breathing exercises or to administer the expectorant. It was also our experience that when no episodic bronchoconstriction had occurred for one or two months, daily routine therapy ceased to be necessary.
An alternative to HEDT. Of the 20 children treated by HEDT, 7 were not rendered completely symptom free after 6 doses in 5 hours, and in these children another method of direct orciprenaline therapy was used. Oral orciprenaline and expectorant were discontinued, and Alupent 5% inhalant solution* was administered as a mist from a Croupaire apparatust. 2*27 1. distilled water were added to 7-5 ml. Alupent 5% inhalant solution, and the resulting very dilute solution was continuously administered (refilling every 12 hours) until the child had been completely 'wheeze-free' for not less than 8 hours. In these 7 cases bronchospasm was successfully and completely eliminated.
School attendance data. 12 of the 46 children satisfied the following conditions: (1) Effect of Orciprenaline on School Absenteeism in Asthma this will be seen that the attendance record of each child improved after starting this treatment and the likelihood of this having occurred by chance is in the region of 1 in 4000 (p < 0-001).
Side-effects In the majority of children (41 out of 46) there were no side-effects and the drug was well tolerated. Of the 3 experiencing side-effects, one had mild diarrhoea, and another had vomiting and 'rambling'. Sleep disturbance and visual hallucination developed in a third, and in this case orciprenaline was discontinued for 3 days and then resumed without further side-effects. A tranquillizing drug was given during the 3-day period. In these 3 children, the side-effects occurred when HEDT was used on several successive days. A fourth patient had developed nausea, and in a fifth swelling of the limbs occurred, but this was during the concurrent adminstration of tetracycline. Edwards (1964) noted that in adults with chronic bronchitis side-effects were no more prominent with 60 mg. orciprenaline daily by mouth than with a placebo. His findings have thus been supported by this study in children where the drug has been shown to be well tolerated over a wide dose range.
Observations
Though this was not a controlled trial in the accepted sense, relevant data concerning the patients were compiled from clinical notes and questionaries, and certain general effects were noted (Table III) .
The effect of orciprenaline was most striking when used during a child's first attack of asthma. These children went home taking a morning and evening dose, and when they had remained 'wheezefree' for several weeks it was possible to discontinue oral therapy.
In no case in this series was it found necessary to resort to treatment with steroids.
Discussion and Summary
Orciprenaline is a sympathomimetic f-adrenergic receptor stimulating drug, the bronchodilator effect of which is considerably more prolonged than that of isoprenaline, whether used by dry aerosol inhalation, as shown by Hoffbrand et al. (1966) , or by aqueous aerosol or oral administration (Edwards, 1964) .
In this series of 46 asthmatic children, studied over a period of 20 months, it has been shown that a highly significant improvement in the severity, duration, and frequency of acute episodes may be 7 achieved by treatment with orciprenaline syrup. This improvement has been reflected in a considerably improved school attendance in all 12 patients to whom this criterion could be applied.
In only 7 patients was control not achieved by the use of orciprenaline orally in association with breathing exercises and an expectorant. In these 7 patients the inhalation of a mist of dilute aqueous orciprenaline solution from a Croupaire apparatus provided an easy method of controlling the patient's asthma.
There is therefore no doubt that Alupent has a significant role in the treatment of childhood asthma, especially in maintaining the best possible attendance at school.
